ABSTRACT. The effect of intrauterine growth retardation (IUGR) on cerebral and adrenal monoamine metabolism was studied in the fetuses of eight nulliparous rat dams after unilateral uterine artery ligation on d 18 of gestation.On d 22 (term = 23 d), four dams were subjected to normoxia and four to hypoxia (10% 0 2 ) for 58 min while their hemodynamics and blood gases were monitored. An inhibitor of L-aromatic-decarboxylase (3-hydroxybensylhydrazine) was infused to measure monoamine synthesis rate. After decapitation of the dam, fetuses were delivered by sectio, decapitated, and dissected at -5OC. The body, liver, forebrain, brainstem, and adrenal glands were weighed, and concentrations of monoamine precursors, transmitters, and metabolites were assessed in the three latter organs. The weights of liver and forebrain were reduced in fetuses with IUGR, whereas brainstem and adrenal weights were unaltered. Epinephrine content in adrenals was reduced in proportion to body weight under normoxia but failed to increase under hypoxia as it did in appropriately grown fetuses. There were only minor changes in monoamine metabolism in the brainstem. In the forebrain, however, marked changes were seen, mainly in serotonin metabolism: under normoxia, fetuses with IUGR had decreased levels of serotonin and its metabolite 5-hydroxyindole acetic acid. Under hypoxia, appropriately grown fetuses reduced their concentrations of these substances, whereas fetuses with IUGR paradoxically increased their synthetic activity. It is concluded that a disturbance of central nervous serotonin metabolism prevails in growth-retarded rat fetuses in late gestation and that this disturbance depends on the degree of growth retardation and the degree of perinatal stress. Fetuses and neonates who are small for gestational age because of IUGR are at increased risk to develop both minor (1, 2) and major (3, 4) neurodevelopmental sequelae. This could be due to an increased risk of asphyxia (5) or an increased sensitivity of the CNS in growth-retarded individuals (6). Indications of an altered central nervous function have been found in growthretarded human fetuses [motor function (7,8) and cardiovascular regulation (9)] and neonates [evoked potentials (lo)]. In growthretarded compared to AGA animal fetuses, changes of cerebral circulation (1 1) and evoked potentials (12) have been shown. Moreover, modifications of evoked potentials (6) and MA metabolism (13) are present in newborn growth-retarded animals when compared with AGA animals.Besides their role as neurotransmitters, MA have trophic effects on cerebral development (14), and manipulations of these systems perinatally have longstanding effects on cerebral function (15) and behavior (16,17). These transmitters, i.e. DA, NE, and 5-HT, have also been implied in the pathophysiology of brain damage from various kinds of stress (18)(19)(20). The growth-retarded fetus often suffers from a mild hypoxia (21) and an insufficient supply of essential amino acids (22), which could influence the synthesis of th...